Lupin

The product will be manufactured at Lupin’s facility in Goa

Agreement enables sustainable patient access of the only EU-approved treatment for myotonia symptoms

Difizma is the only FDC that has been approved by the Drug Controller General of India (DCGI) for the treatment of inadequately…

These labs are equipped with qualified clinical experts and automated and streamlined processes

The product will be manufactured at Lupin’s facility in Nagpur, India

The company's product -- Diclofenac Sodium Topical Solution 2% -- is the generic version of Horizon Pharma Therapeutics Pennsaid

Rufinamide is indicated for the treatment of the symptoms of Lennox-Gastaut Syndrome

The company tends to market a generic equivalent of Perforomist Inhalation Solution, 20 mcg/2 mL, of Mylan Specialty

As part of the transaction, MedQuímica will acquire rights to nine products including Limbitrol, Melleril and Dalmadorm for…

India formulation sales for Q2 FY2023 were Rs 15,841 mn, up 6.2 per cent as compared to Rs 14,920 mn in Q1 FY2023